Two projects of Arjen Blom and Peter van Lent, theme Inflammatory diseases, were granted by the Dutch Arthritis Association (ReumaNederland) (€ 160,000 per project).
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Arjen Blom will focus on novel tools for imaging of early cartilage destruction for diagnostic purposes in rheumatic diseases.
Peter van Lent will focus on the therapeutic efficacy of fat derived stem cells in dampening synovitis and development of joint destruction in posttraumatic OA.
Related news items
Biomaterials-aided mandibular reconstruction using in vivo bioreactors22 March 2019
In a collaborative effort, John Jansen en Jeroen van den Beucken, theme Reconstructive and regenerative medicine, have demonstrated in PNAS the feasibility of an in vivo bioreactor-based strategy to generate vascularized bony tissue and its use for mandibular reconstruction.read more
Lieneke Steeghs about the PATH project: Predictive Analysis for Therapy22 March 2019
Read here the article 'PATH makes predictive molecular diagnostics in cancer unambiguous', of Lieneke Steeghs, theme Tumors of the digestive tract, that was published on the website of ZonMw.read more